Bulletin Contents
Search
Home Page
 
*Satellos Bioscience Inc. 
Listed Company 

ICO THERAPEUTICS INC. ("ICO")
BULLETIN TYPE: Prospectus-Unit Offering
BULLETIN DATE: January 28, 2014
TSX Venture Tier 2 Company

Effective January 22, 2014, the Company's Prospectus dated January 22, 2014 was filed with and accepted by TSX Venture Exchange. The Company's Short Form Base Shelf Prospectus dated July 3, 2012 was filed with and receipted by the British Columbia, Alberta and Ontario Securities Commissions, pursuant to the provisions of the British Columbia Securities Act on July 3, 2012.

TSX Venture Exchange has been advised that closing occurred on January 27, 2014, for gross proceeds of $6,750,000.17.

Agent.: Euro Pacific Canada Inc

Offering: 16,206,463 units. Each unit consisting of one share and three quarters (3/4) of one warrant to purchase one share.

Unit Price: $0.4165 per unit

Warrant Exercise Price/Term: $0.539 per share to January 27, 2019.

Agents' Warrants: N/A
________________________________________